Star Scientific and Dirty Politics

Published: Monday, May 13, 2013 5:17 AM PDT

Dr. John L. Faessel ON THE MARKET Commentary and Insights Dirty Politics 101 – Really Dirty… Star Scientific (STSI) Nasdaq Classic logical fallacy: argumentum ad hominemand deconstructing the argument to fallacy ad hominem 1: appealing to feelings or prejudices rather than intellect 2: marked by or being an attack on an opponent's character rather than by an answer to the contentions made hokum 1. Something apparently impressive or legitimate but actually untrue or insincere; nonsense. 2. A stock technique for...

Rating 5

Stupid Stuff We Were Saying About Vringo (VRNG) a Year Ago

Published: Tuesday, April 30, 2013 10:45 AM PDT

One year out from all the Vringo, Inc. (NYSE:VRNG), it's pretty safe to say the stock's been a big fat disappointment.

Rating 5

Cloud Star (CLDS) Just Put Enough Gas in the Tank to Get There

Published: Wednesday, May 1, 2013 10:43 AM PDT

Cloud Star Corp. (OTCBB:CLDS) was already on a roll, but today's reload just put the pedal to the metal.

Rating N/A

Advanced Micro Devices (AMD) Is The Real Deal... Again

Published: Wednesday, May 1, 2013 8:27 AM PDT

Advanced Micro Devices, Inc. (NYSE:AMD) had a miserable 2012 and a lethargic start to 2013. But, this week's move speaks volumes about how the tide has turned.

Rating N/A

How To Begin Trading Stocks

Published: Tuesday, April 30, 2013 4:38 PM PDT

First off to trade on the stock market you will need to get a broker. Now if you're going to be trading online like many people do nowadays this will be easy. All you have to do is pick one out of a long list and decide what it is you want from your broker. Major things that you need to consider are: Commission rates ($4-10)Minimum balance required (usually around $500)reliability/ ease of useResearch options These are just the main things you want to look at. If you go with one of the major ones such as E-trade...

Rating N/A

All VIVUS (VVUS) Needed To Do Was Get the Ball Rolling

Published: Thursday, May 23, 2013 12:50 PM PDT

VIVUS, Inc. (NASDAQ:VVUS) has been spinning its wheels for quite some time, but today's breakout is apt to create the very melt-up the market was waiting to see.

Rating N/A

Why Interest is Growing in Cancer Genetics

Published: Thursday, May 23, 2013 11:25 AM PDT

Cancer Genetics (OTCQB: CGIX), a developer of DNA-based cancer diagnostics, is one of the most compelling opportunities we've seen in 2013.

Rating N/A

Lattice CEO Interviewed by The Wall Street Analyst

Published: Thursday, May 23, 2013 11:19 AM PDT

Paul Burgess, CEO of Lattice Inc. (OTCBB: LTTC), a provider of secure cloud-based communications technology for correctional facilities, was recently interviewed by The Wall Street Analyst.

Rating N/A

Amarin Stays Rangebound, Prescriptions Stagnate

Published: Thursday, May 23, 2013 11:08 AM PDT

Amarin, on the whole, seems to have fallen out of favor in the biotech investment community. This may change as we head closer to December 20th (or after an unexpected announcement), but without a tangible piece of news that can positively affect Vascepa’s sales figures or its financial valuation don’t expect much more than a continuation of what we’ve seen this year.

Rating N/A

Do We Trust Spectrum Pharmaceuticals (SPPI) Here?

Published: Thursday, May 23, 2013 7:54 AM PDT

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is rolling again. Take it at face value.

Rating N/A
First « Previous 1 2 3 4 5 6 7 8 9 10 11 Next » Last
Join the 200,000+ other Members who take full advantage of all the SmallCap Network has to offer: Sign In or Join